NCT06462313

N/AInterventional

Trials without FDA-defined phases, including trials of devices or behavioral interventions.

View on ClinicalTrials.gov ↗

Timeline

Start date: Jul 22, 2024
Primary completion: Apr 30, 2027
Completion date: Apr 30, 2027
First posted: Jun 17, 2024
Last posted: Jul 24, 2024
Enrollment: 584
Arms / groups: 2 / —
Source: AACT · ctgov ingestion

Sponsors

Zhejiang UniversityLead sponsor
Henan Provincal People's HospitalCollaborator
Wuhan UniversityCollaborator
Tianjin Medical UniversityCollaborator
Zunyi Medical CollegeCollaborator
Xinjiang Medical UniversityCollaborator
Xinjiang Medical UniversityCollaborator
Nanchang UniversityCollaborator
Zhejiang UniversityCollaborator
Lishui Country People's HospitalCollaborator
Ningbo No. 2 HospitalCollaborator
Red Cross Hospital, Hangzhou, ChinaCollaborator
Anhui Medical UniversityCollaborator
Fujian Provincial HospitalCollaborator
People's Liberation Army of ChinaCollaborator
Huazhong University of Science and TechnologyCollaborator
Weifang People's HospitalCollaborator
Huazhong University of Science and TechnologyCollaborator
Zhejiang UniversitySponsor investigator
Fujian Medical UniversityCollaborator
Weihai Municipal HospitalCollaborator
Ningbo No. 1 HospitalCollaborator
Shihezi University Medical CollegeCollaborator
Southern Medical UniversityCollaborator
Zhengzhou UniversityCollaborator
Chinese Academy of Medical SciencesCollaborator
The First People’s Hospital of ZunyiCollaborator
Guangdong Medical UniversityCollaborator
The Central Hospital of Lishui CityCollaborator
Soochow UniversityCollaborator
Wenzhou Medical UniversityCollaborator
University of South ChinaCollaborator
University of South ChinaCollaborator
Guizhou Medical UniversityCollaborator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.